Congratulations to Dr. David Cherney and his research consortium in receiving the 2021 CIHR - Kidney Foundation team grant in Diabetes to support SUGARNSALT collaborative studies in type 1 diabetes CIHR University Health Network Gillian Hawker UHN Foundation Kidney Foundation

In the November issue of 'The Krembil,' learn more about our newest Alzheimer's scientist and clinician, Dr. Martin Ingelsson, an historic gift for vision research and the launch of the 2021 Krembil Annual Report >> bit.ly/3Dlvvvj Krembil Brain Institute Schroeder Arthritis Institute

BREAKING NEWS! Canadian Provincial governments have agreed to move forward to negotiate access to Luxturna! Visit approveluxturna.ca to send an email to your Premier & your Health Minister with a new message - to expedite negotiating access to Luxturna NOW. #ApproveLuxturna

Novartis announces positive results from year two of the Phase III trial of Beovu in diabetic macular edema ophthalmologytimes.com/view/novartis-… via Ophthalmology Times

Teleretinal screening for #DiabeticRetinopathy provides effective disease monitoring ophthalmologytimes.com/view/teleretin… via Ophthalmology Times Europe Fighting Blindness Canada is supporting a major screening #diabetes Diabetes Action Can. called Project Open - thanks to support from TD (Canada)

Novartis inks $800M upfront buyout of Gyroscope to continue eye disease gene therapy M&A spree key is a gene therapy, GT005, that is in phase 2 development as a treatment for geographic atrophy fiercebiotech.com/biotech/novart…

Our new meta-analysis in Retina of over 1 million patients shows no association between the use of statins and the incidence of age-related macular degeneration: journals.lww.com/retinajournal/… Thank you to my coauthors on this important work. #Ophthalmology #retina

Our meta-analysis in collaboration with Diabetes Action Can. validates that teleretinal screening is highly accurate for diagnosis of #DiabeticRetinopathy, while evidence for diagnosis of #AMD is more limited. Can Ophthal Society Krembil Brain Institute Fighting Blindness Canada IHPME bmjophth.bmj.com/content/7/1/e0…

So Cool!

We need public coverage of Luxturna now ... Adam is losing 10,000 photoreceptors a day while government dithers - send an email to your Premier now ApproveLuxturna.ca Fighting Blindness Canada healthing.ca/partners/ird/h…

New publication from Tina Felfeli, MD PhD and DAC’s Michael Brent looks at accuracy of teleretinal screening for diabetic retinopathy. diabetesaction.ca/new-paper-high…

New study seeks to expand eye screenings for rural diabetic patients throughout the United States med.wisc.edu/news-and-event…

Prevalence and predictors for being unscreened for diabetic retinopathy: a population-based study over a decade canadianjournalofophthalmology.ca/article/S0008-… Tina Felfeli, MD PhD Michael Brent Fighting Blindness Canada

Retrospective study compares AI, teleophthalmology diagnosis for diabetic retinopathy modernretina.com/view/retrospec… via @modernretina

J&J buys an early-stage gene therapy for the eye — the only known program for an under-the-radar biotech - endpts.com/jj-buys-an-ear…

Preserving sight for people with diabetes /via The Globe and Mail featuring research from Val Rac @TGHRI_UHN Ted Rogers Centre for Heart Research University Health Network theglobeandmail.com/life/adv/artic…

Ms. Debbie Sissmore and her husband, Mr. Malcolm Sissmore have been guiding our provincial and national diabetic retinopathy screening initiatives and evaluations since their conceptualization. Their continuous engagement and input are crucial.

Eye screening for diabetic retinopathy is important for avoiding sight-threatening complications but there are +++ barriers. Our co-development of a linguistically/culturally tailored theory-informed intervention to support access & screening: bmchealthservres.biomedcentral.com/articles/10.11… CIR

Yesterday, we celebrated the opening of our new Clinical Research Unit Donald K. Johnson Eye Institute. The CRU will bring together clinicians and researchers, to translate basic science discoveries into clinical applications, to help preserve and restore vision.